The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
 
Nathan Bahary
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene
Research Funding - Newlink Genetics
 
Andrea Wang-Gillam
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Jacobio; Merrimack; Vicus Therapeutics
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); EMD Serono (Inst); Halozyme (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); pfizer (Inst); Plexxikon (Inst); Precision Therapeutics (Inst); Roche (Inst); Verastem (Inst)
 
Sigurdis Haraldsdottir
No Relationships to Disclose
 
Bradley G. Somer
No Relationships to Disclose
 
Jin S. Lee
No Relationships to Disclose
 
Mark Allen O'Rourke
Stock and Other Ownership Interests - Novacyt
 
Asha Nayak-Kapoor
No Relationships to Disclose
 
Gregory Lawrence Beatty
Stock and Other Ownership Interests - Advaxis; Johnson & Johnson
Honoraria - Incyte; Janssen
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Incyte; Opsona Therapeutics; Seagen; Vaccinex
Research Funding - Biothera; Bristol-Myers Squibb; Halozyme; Incyte; Janssen; Newlink Genetics; Novartis; Verastem
Patents, Royalties, Other Intellectual Property - Inventor of intellectual property related to mesothelin CAR T cells that is licensed by the University of Pennsylvania to Novartis.
 
Mingen Liu
No Relationships to Disclose
 
Devora Delman
No Relationships to Disclose
 
Gabriela R. Rossi
Employment - Newlink Genetics
Stock and Other Ownership Interests - Newlink Genetics
 
Eugene Paul Kennedy
Employment - CSL Limited (I); Newlink Genetics
Stock and Other Ownership Interests - Newlink Genetics
 
Nicholas N. Vahanian
Employment - Newlink Genetics
Leadership - Newlink Genetics
Stock and Other Ownership Interests - Newlink Genetics
 
Charles J. Link
Employment - Newlink Genetics
Leadership - Newlink Genetics
Stock and Other Ownership Interests - Newlink Genetics
 
Ignacio Garrido-Laguna
No Relationships to Disclose